Andrew Mark Gutmann
Corporate Officer/Principal at Beaufort International Associates Plc
Profile
Andrew Mark Gutmann is currently the Head of Capital Markets at Beaufort International Associates Plc.
He previously worked as a Non-Executive Director at OKYO Pharma Ltd., Alexander David Investments Plc, and Tiziana Life Sciences Ltd.
(United Kingdom).
Andrew Mark Gutmann active positions
| Companies | Position | Start |
|---|---|---|
Beaufort International Associates Plc
 Beaufort International Associates Plc Investment ManagersFinance Beaufort International Associates Plc provides stock broking services to private clients. It also offers corporate financial and settlement services to regulated firms. The company was founded in 1998 and is headquartered in London, the United Kingdom. | Corporate Officer/Principal | - |
Former positions of Andrew Mark Gutmann
| Companies | Position | End |
|---|---|---|
| OKYO PHARMA LIMITED | Director/Board Member | 2018-01-09 |
Tiziana Life Sciences Ltd. (United Kingdom)
 Tiziana Life Sciences Ltd. (United Kingdom) BiotechnologyHealth Technology Tiziana Life Sciences Ltd. engages in the development of therapies for neurodegenerative and lung diseases. Its clinical pipeline includes Foralumab, Anti IL-6R, and Milciclib. The company was founded by Gabriele Marco Antonio Cerrone on February 11, 1998 and is headquartered in London, the United Kingdom. | Director/Board Member | 2015-01-22 |
Alexander David Investments Plc
 Alexander David Investments Plc Financial ConglomeratesFinance Alexander David Investments Plc operates as an investment company. Its investment targets are small cap and special opportunities with a current bias towards basic resources and oil and gas sectors. The company was founded on February 11, 1998 and is headquartered in London, the United Kingdom. | Director/Board Member | 2014-04-23 |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 1 |
|---|---|
| OKYO PHARMA LIMITED | Health Technology |
| Private companies | 3 |
|---|---|
Beaufort International Associates Plc
Beaufort International Associates Plc Investment ManagersFinance Beaufort International Associates Plc provides stock broking services to private clients. It also offers corporate financial and settlement services to regulated firms. The company was founded in 1998 and is headquartered in London, the United Kingdom. | Finance |
Alexander David Investments Plc
Alexander David Investments Plc Financial ConglomeratesFinance Alexander David Investments Plc operates as an investment company. Its investment targets are small cap and special opportunities with a current bias towards basic resources and oil and gas sectors. The company was founded on February 11, 1998 and is headquartered in London, the United Kingdom. | Finance |
Tiziana Life Sciences Ltd. (United Kingdom)
Tiziana Life Sciences Ltd. (United Kingdom) BiotechnologyHealth Technology Tiziana Life Sciences Ltd. engages in the development of therapies for neurodegenerative and lung diseases. Its clinical pipeline includes Foralumab, Anti IL-6R, and Milciclib. The company was founded by Gabriele Marco Antonio Cerrone on February 11, 1998 and is headquartered in London, the United Kingdom. | Health Technology |
- Stock Market
- Insiders
- Andrew Mark Gutmann
